URG4与临床病理学参数之间的关系及其对胃癌两年生存率的影响
1Clinic of Pathology, Konya City Hospital, University of Health Sciences, Konya, Turkey.
Translational oncology
|September 26, 2024
概括
上调4基因 (URG4) 表达与胃癌中晚期瘤阶段和淋巴血管入侵相关. 增加URG4表达与更短的生存期和更高的死亡率有关,这表明其预后价值.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 是全球癌症死亡的主要原因之一.
- 早期诊断和有效的预后标记对于改善患者的治疗结果至关重要.
- 上调基因4 (URG4) 是一种瘤基因,与胃癌的发展有关.
研究的目的:
- 调查URG4表达和GC中的临床病理参数之间的关系.
- 评估URG4对GC患者2年生存期的预后意义.
- 将URG4的预后值与人类表皮生长因子受体2 (HER2) 状态进行比较.
主要方法:
- 分析了来自61名GC患者的氨酸嵌入瘤样本中的URG4表达.
- URG4表达水平与临床病理特征相关,包括瘤阶段和淋巴血管入侵 (LVI).
- 评估了URG4表达与2年生存率和死亡率之间的关联.
主要成果:
- URG4表达与晚期瘤 (T) 阶段和LVI (p < 0.005) 有显著的相关性.
- 高URG4表达与2年生存率降低和死亡率增加有关 (p < 0.05).
- 在预测患者存活率方面,URG4的预后表现与HER2相似.
结论:
- 在胃癌中,URG4是一个重要的瘤基因,与具有侵略性瘤特征相关.
- 在GC患者中,URG4表达是生存的有价值的预后因素.
- 需要进一步研究URG4在GC预后和治疗中的作用.
相关概念视频
01:21Cancer Survival Analysis
331
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
331
01:20Comparing the Survival Analysis of Two or More Groups
158
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
158